Wells Fargo Maintains Overweight on Nucor, Lowers Price Target to $285

Benzinga Newsdesk www.benzinga.com Negative 89.7%

Neg 89.7% Neu 0% Pos 0%

Wells Fargo analyst Timna Tanners maintains Nucor (NYSE:NUE) with a Overweight and lowers the price target from $297 to $285.